Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Regulatory Dendritic Cell (DCreg) Therapy in Live-Donor Renal Transplant Recipients

NCT03726307 is registered in ClinicalTrials.gov with Angus W. Thomson PhD DSc as lead sponsor.

NCT NCT03726307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03726307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Regulatory Dendritic Cell (DCreg) Therapy in Live-Donor Renal Transplant Recipients
Lead sponsor
Angus W. Thomson PhD DSc
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 10, 2019
Completion date
May 31, 2028
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant, renal transplant recipients